发明名称 |
Baclofen formulations and methods for making same |
摘要 |
Methods for preparing sterilized baclofen solutions include adjusting the pH to below a desired pH, and steam sterilizing the solution with adjusted pH, which results in the solution having the desired pH. Such solutions may also have low concentrations of 4-CPP. Injectable baclofen solutions having greater than 2 mg/mL baclofen include between 5 mM and 25 mM of a phosphate or sulfate species. The solution has an ionic strength equivalent of about 1.5 M NaCl. The present application also provides baclofen formulations for use in treating spasticity, brain injury, cerebral palsy, spinal cord injury, cervical injury, multiple sclerosis, thoracic injury, or withdrawal symptoms. |
申请公布号 |
US9180108(B2) |
申请公布日期 |
2015.11.10 |
申请号 |
US201213661800 |
申请日期 |
2012.10.26 |
申请人 |
Medtronic, Inc. |
发明人 |
Schmitz Michael C.;Dominguez Corinne;Keene Thomas E.;Lane Deanna S.;Le Lanchi T.;Li Jianwei;Lu Ngoc T.;Snaza Carmen E. |
分类号 |
A61K31/197;A61K9/08;A61L2/07;A61P21/02;A61K9/00 |
主分类号 |
A61K31/197 |
代理机构 |
Sorell, Lenna & Schmidt LLP |
代理人 |
Schmidt William D.;Sorell, Lenna & Schmidt LLP |
主权项 |
1. An injectable baclofen solution, the solution comprising:
baclofen in a concentration greater than 2 mg/mL; sulfate or phosphate in a concentration of between 10 mM and 25 mM, wherein the solution has an ionic strength equivalent of between 1, the solution c.4 M NaCl and 1.6 M NaCl comprising less than 1.3% of 4-(4-chlorophenyl)-2-pyrrolidinone (4-CPP) after at least 30 days of storage at room temperature, wherein the solution has a pH between about 5.5 and 6.5. |
地址 |
Minneapolis MN US |